Table 1. Intracavernosal pharmacotherapies.

Trade name	Drug	Dosage	Effectiveness(%)
Caverject	Alprostadil	5–40 ìg/mL	≈70
EDEX	Alprostadil	5–40 ìg/mL	≈70
Bi-Mix	Alprostadil + phentolamine	20 ìg/mL + 0.5 mg/mL	≈90
Bi-Mix (adroskat EU)	Papaverine + phentolamine	30+0.5 mg/mL	≈90
Tri-Mix	Papaverine + alprostadil + phentolamine	10 ìg/mL + 30 mg/mL + 1 mg/mL	≈90
Invicorp	VIP + phentolamine	–	≈70

VIP, vasoactive intestinal peptide.